Hematologic complications of HIV infection

ONCOLOGY

Volumn 10, Issue 5, 1996, Pages 671-680

  Hambleton, Julie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CLARITHROMYCIN; COLONY STIMULATING FACTOR 1; DAPSONE; DIDANOSINE; ERYTHROPOIETIN; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 3; PENTAMIDINE; PENTAMIDINE ISETHIONATE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RIFABUTIN; STAVUDINE; ZIDOVUDINE;

BLOOD CLOTTING DISORDER; BLOOD DISEASE; CYTOPENIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPENIA; NEUTROPENIA; REVIEW; THROMBOCYTOPENIA;

BLOOD COAGULATION DISORDERS; BONE MARROW EXAMINATION; COLONY-STIMULATING FACTORS; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC DISEASES; HIV INFECTIONS; HUMANS; PRACTICE GUIDELINES;

EID: 0029971201     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Doweiko JP: Hematologic aspects of HIV infection. AIDS 7:753-757, 1993.
2. Perkocha L, Rodgers G: Hematologic aspects of human immunodeficiency virus infection: Laboratory and clinical considerations. Ann J Hematol 29:94-105, 1988.
3. Harbol AW, Liesveld JL, Simpson-Haidaris PJ, et al: Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev 8(4):241-251, 1994.
4. Donahue R, Johnson M, Zon L: Suppression of in vitro hematopoiesis following human immunodeficiency virus infection. Nature 326:200-203, 1987.
5. Scadden D, Zon L, Groopman J: Pathophysiology and management of HIV-associated hematologic disorders. Blood 74:1455-1463, 1989.
6. Zon L, Groopman J: Hematologic manifestations of the human immune deficiency virus. Semin Hematol 25:208-218, 1988.
7. Spivak J, Barnes DC, Fuchs E, et al: Serum immunoreactive erthropoietin in HIV-infected patients. JAMA 261:3104-3107, 1989.
8. Fauci A, Schnittman S, Polii G: Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 114:678-693, 1991.
9. Zhang Y, Harada A, Bluethmann H, et al: Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic cells: Increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF in vitro. Blood 86(8):2930-2937, 1995.
10. Gascom P, Sathe S, Rameshwar P: Impaired erythropoiesis in the acquired immunodeficiency syndrome with disseminated mycobacterium avium complex. Am J Med 94:41-48, 1993.
11. Chernak E, Dubin G, Henry D, et al: Infection due to parvovirus B19 in patients infected with hum'an immunodeficiency virus. Clin Infect Dis 20(1):170-173, 1995.
12. Gyllensten K, Sonnerborg A, Jorup-Ronstrom C, et al: Parvovirus B19 infection in HIV-1 infected patients with anemia. Infection 22(5):356-358, 1994.
13. Frickhofen N, Abkowitz JL, Safford M, et al: Persistent B19 parvovirus infection in patients infected with HIV type 1: A treatable cause of anemia in AIDS. Ann Intern Med 113:926-933, 1990.
14. Naides S, Howard EJ, Swack NS, et al: Parvovirus B19 infection in HIV type 1-infected persons failing or intolerant to zidovudine therapy. J Infect Dis 168:101-105, 1993.
15. Bremner J, Beard B, Cohen A: Secondary infection with parvovirus B19 in an HIV-positive patient. AIDS 7:1131-1132, 1993.
16. McGinniss M, Macher A, Rook A, et al: Red cell autoantibodies in patients with acquired immune deficiency syndrome. Transfusion 26:405-409, 1986.
17. Toy P, Reid M, Burns M: Positive direct antiglobulin test associated with hyperglobulinemia in acquired immunodeficiency syndrome. Am J Hematol 19:145, 1985.
18. Harriman G, Smith P, Horne M: Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome Arch Intern Med 149:2039-2041, 1989.
19. Ehrenpreis E, Carlson SJ, Boorstein HL, et al: Malabsorption and deficiency of vitamin B12 in HIV-infected patients with chronic diarrhea. Dig Dis Sci 39(10):2159-2162, 1994.
20. Paltiel O, Falutz J, Veilleux M, et al: Clinical correlates of subnormal vitamin B12 levels in patients infected with the human immunodeficiency virus. Am J Hematol 49(4).318-322, 1995.
21. Richman D: AZT collaborative working group:The toxicity of azidothymidine in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 317:192-197,1987.
22. Brizzi M, Porcu P, Porteri A, et al: Haematologic abnormalities in the acquired immunodeficiency syndrome. Haematologica 75:454-463, 1990.
23. Israel D, Plaisance K: Neutropenia in patients infected with human immunodeficiency virus. Clin Pharm 10: 268-279, 1990.
24. Leiderman I, Greenberg M, Adelsberg B, et al: A glycoprotein inhibitor of in vitro granulopoiesis associated with AIDS. Blood 70:1267-1272, 1987.
25. Murphy M, Metcalfe P, Waters A: Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 66:337-340, 1987.
26. Murphy P, Lane C, Fauci A, et al: Impairment of neutrophil bactericidal capacity in patients with AIDS. J Infect Dis 158:627-630, 1988.
27. Valonc F, Payan D, Abrams D, et al: Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. J Infect Dis 150:267-271, 1984.
28. Karpatkm S: Immunologic thrombocytopenic purpura in HIV-seropositive homosexuals, narcotic addicts and hemophiliacs. Semin Hematol 25:219-229, 1988.
29. Battaieb A, Fromont P, Louache F, et al: Presence of cross-reactive antibody between HIV and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood 80:162-169, 1992.
30. Louache F, Bettaieb A, Henri A, et al: Infection of megakaryocytes by HIV in seropositive patients with immune thrombocytopenic purpura. Blood 78:1697-1705, 1991.
31. Zucker-Franklin D, Termin C, Cooper M: Structural changes in the megakaryocytes of patients infected with HIV-1. Am J Pathol 134:1295-1303, 1989.
32. Zucker-Franklin D, Seremetius S, Zheng Z: Internalization of HIV-type 1 and other retroviruses by megakaryocytes and platelets. Blood 75:1920-1923, 1990.
33. Oksenhendler E, Bierling P, Chevret S, et al: Splenectomy is safe and effective in HIV-related immune thrombocytopenia. Blood 82:29-32, 1993.
34. Schneider P, Abrams D, Rayneret A, et al: Immunodeficiency-associated thrombocytopenic purpura: Response to splenectomy. Arch Surg 122:1175-1178, 1987.
35. Yap PL, Todd AAM, Williams PE, et al: Use of intravenous immunoglobulin in acquired immune deficiency syndrome. Cancer 68:1440-1450, 1991
36. Oksenhendler E, Bierling P, and Ferchal F: Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus infection. Ann Intern Med 110:365-368, 1989.
37. Swiss Group for Clinical Studies on AIDS: Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus. Ann Intern Med 109:718-721, 1988.
38. Stellini R, Rossi G, Paraninfo G: Interferon therapy in intravenous drug users with HIV-associated idiopathic thrombocytopenic purpura. Haematologica 77:418-420, 1992
39. Vianelli N, Cantai L, Gugliotta L: Recombinant alpha Interferon 2b in the therapy of HIV-related thrombocytopenia. AIDS 7:823-827, 1993.
40. Fabris F, Sgarabotto D, Zanon E, et al: The effect of a single course of alpha-2B-interferon in patients with HIV-related and chronic idiopathic immune thrombocytopenia. Autoimmunity 14(3):175-179, 1993.
41. Rossi E, Damasio E, Terragna A: HIV-related thrombocytopenia: A therapeutical update. Haematologica 76:141-149, 1991.
42. Gringeri A, Cattaneo M, Santagostino E, et al: Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura. Br J Haematol 80(3):337-340, 1992.
43. Bussel J, Graziano JN, Kimberly RP, et al: Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect. Blood 77(9):1884-1893, 1991.
44. Groopman J: Zidovudine intolerance. Rev Infec Dis 12(suppl 5):S500-506, 1990.
45. Gill P, Rarick M, Brynes R: Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome. Ann Intern Med 107:502-505, 1987.
46. Walker R, Parker R, Kovacs J: Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome and Kaposi sarcoma treated with zidovudine. Ann Intern Med 108:372-376, 1988.
47. Hambleton J, Aragon T, Modin G, et al: Outcome for hospitalized patients with fever and neutropenia who are infected with the human immunodeficiency virus. Clin Infect Dis 20:363-371, 1995.
48. Roubey RAS: Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 84(9):2854-2867, 1994.
49. Bloom E, Abrams D, Rodgers G: Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 256:491-493, 1986.
50. Leaf A, Laubenstein L, Raphael B: Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 infection. Ann Intern Med 109:194-197, 1988.
51. Nair J, Bellevue R, Bertoni M, et al: Thrombotic thrombocytopenic purpura in patients with the acquired immunodeficiency syndrome-related complex. Ann Intern Med 109:209-212, 1988.
52. Thompson C, Damon LE, Ries CA, et al: Thrombotic microangiopathies in the 1980s: Clinical features, response to treatment, and the impact of the HIV epidemic. Blood 80:1890-1895, 1992.
53. Candido A, Rossi P, Menichella G, et al: Indicative morphological myelodysplastic alterations of bone marrow in overt AIDS. Haematologica 75(4):327-333, 1990.
54. Goasguen J, Bennett J: Classification and morphologic features of the myelodysplastic syndromes. Semin Oncol 19:4-13, 1992.
55. Harris C, Biggs JC, Concannon AJ, et al: Peripheral blood and bone marrow findings in patients with acquired immune deficiency syndrome. Pathology 22(4):206-211, 1990.
56. Sasadeusz J, Buchanan M, Speed B: Reactive haemophagocytic syndrome in human immunodeficiency virus infection. J Infect 20(1):65-68, 1990.
57. Abrams D, Chinn E, Lewis B: Hematologic manifestations in homosexual men with Kaposi's sarcoma. Am J Clin Pathol 81:13-18, 1984.
58. Castella A, Croxson T, Mildvan D: The bone marrow in AIDS: A histologic, hematologic. and microbiologic study. Am J Clin Pathol 84:425-432, 1985.
59. Mehta K, Gascon P, Robboy S: The gelatinous bone marrow (serous atrophy) in patients with acquired immunodeficiency syndrome. Evidence of excess sulfated glycosaminoglycan. Arch Pathol Lab Med 116(5):504-508, 1992.
60. Northfelt D, Mayer A, Kaplan L: The usefulness of diagnostic bone marrow examination in patients with HIV infection. J Acquir Immune Defic Syndr 4:659-666, 1991.
61. Groopman J, Feder D: Hematopoietic growth factors in AIDS. Semin Oncol 19:408-414, 1992.
62. Miles S: The use of hematopoietic growth factors in HIV infection and related malignancies Cancer Invest 9:229-238, 1991.
63. Miles S: Hematopoietic growth factors as adjuncts to antiretroviral therapy. AIDS Res Hum Retroviruses 8:1073-1079, 1992
64. Groopman J: Management of the hematologic complications of human immunodeficiency virus infection. Rev Infect Dis 12:931-937, 1990.
65. Baldwin C, Gassou J, Quan S: Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc Natl Acad Sci USA 85.2763-2766, 1988.
66. Groopman J, Mitsuyasu R, DeLeo M: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 317:593-598, 1987
67. DaCosta N, Hultin M: Effective therapy of human immunodeficiency virus-associated anemia with recombinant human erythropoietin despite high endogenous erythropoietin. Am J Hematol 36:71-72,1991.
68. Henry D, Beall G, Benson C: Recombinant human erythropoietin in the therapy of anemia associated with HIV infection and zidovudine therapy: Overview of four clinical trials. Ann Intern Med 117:739-748, 1992.